Lamisil Once (Terbinafine Hydrochloride)

Terbinafine Hydrochloride blocks the fungal enzyme squalene epoxidase, preventing the synthesis of ergosterol, an essential component of fungal cell membranes. This leads to accumulation of toxic squalene and disruption of the membrane, causing fungal cell death.

The specific dose and duration of Lamisil Once are determined by the prescribing healthcare professional based on the infection type, severity, patient age and other clinical factors. Patients should follow the prescriber’s instructions exactly.

Safety data for topical terbinafine during pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing Lamisil Once to pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamisil Once belongs to the allylamine class, which acts on fungal squalene epoxidase, whereas many alternatives such as azoles inhibit lanosterol 14α‑demethylase. Allylamines often achieve rapid fungicidal activity and are effective for dermatophyte infections, offering a different mechanism that can be useful when azole resistance is a concern.

Lamisil Once should be stored at room temperature, below 25 °C, in its original container. Keep the product away from excess moisture and direct sunlight to maintain its stability and potency.

Apply a thin layer of the cream or gel to the affected skin area once daily, or as directed by the prescriber. Gently rub it in until it disappears, and wash hands before and after application to avoid spreading the medication to other sites.

While uncommon, serious adverse reactions can include severe allergic responses such as anaphylaxis, extensive swelling, blistering, or rare conditions like Stevens‑Johnson syndrome. Patients should discontinue use and seek immediate medical attention if they notice any of these symptoms.

Lamisil Once should not be used on broken, inflamed or infected skin unless specifically advised by a healthcare professional. Individuals with a known hypersensitivity to terbinafine or any component of the formulation should avoid using the product.